NCT04807179 is a NA clinical trial of Experimental: RF Device Arm in Acne Scars, sponsored by Cynosure, Inc..

Who is sponsoring NCT04807179?

NCT04807179 is sponsored by Cynosure, Inc..

What drugs are being tested in NCT04807179?

Interventions in NCT04807179: Experimental: RF Device Arm.

What condition does NCT04807179 study?

NCT04807179 studies Acne Scars.

Is NCT04807179 still recruiting?

NCT04807179 is currently active, enrolled. Last updated 7 May 2024.

Last reviewed 2024-05-07 · How we verify

NCT04807179

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Study to Evaluate Alexandrite Laser for the Treatment of Acne Scars

Active, enrolled NA Last updated 7 May 2024

What this trial tests

NA trial testing Experimental: RF Device Arm in Acne Scars in 39 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

8 March 2021

Primary endpoint
2 August 2024

2 August 2024

Quick facts

Lead sponsor	Cynosure, Inc.
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	39
Start date	8 March 2021
Primary completion	2 August 2024
Estimated completion	2 August 2024
Sites	2 locations across United States

Drugs / interventions tested

Experimental: RF Device Arm

Conditions studied

Acne Scars — all drugs for Acne Scars →

Sponsor

Cynosure, Inc. — full company profile →

Who can join

Adults 18 to 65, any sex, with Acne Scars. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The intended use of the Alexandrite laser device used in this study is to assess the efficacy and safety of the Alexandrite laser device for the treatment of acne scars on skin types V and VI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acne Scars

Currently open trials in the same condition.

NCT07368764 — The Suitability of Tience® for Treating Acne Scars · NA · recruiting

Other Cynosure, Inc. trials

Trials by the same sponsor.

NCT05847530 — Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions · NA · completed
NCT06023303 — Prospective Clinical Study to Assess Safety and to Collect Data on Radiofrequency Microneedling Device(s) For the Purpos · NA · completed
NCT05590039 — Study To Evaluate The Safety And Efficacy Of The MyEllevate® Procedure · NA · completed
NCT05388604 — Clinical Study To Evaluate Paired Treatment With An Alexandrite Laser And Radiofrequency Microneedling For Facial Aging · NA · completed
NCT05388617 — Study To Assess Radiofrequency Diathermocontraction Device For Muscle Stimulation And The Treatment Of Abdominal Fat · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04807179 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cynosure, Inc.
Last refreshed: 7 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04807179.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing